Gastroenterology
Margin Recovery for Independent Gastroenterology Practices
GI economics are procedural economics. Most of the recoverable margin in a gastroenterology group sits in the endoscopy suite schedule, the ancillary lines attached to it, and the recall engine that keeps the suite full.
How the Economics Actually Work
A GI practice does not make its money in the office. It makes it in the procedure suite, and the suite is either full and running on time or it is quietly destroying the practice's margin. A single unfilled endoscopy block costs more than a week of office no-shows, and most groups cannot tell you their block utilization without pulling a report by hand.
The second thing that separates a strong GI group from an average one is the ancillary stack. Pathology, anesthesia arrangements, and infusion for IBD patients are all margin lines that can either be optimized or left on the table. Groups that have never modeled their pathology arrangement against alternatives are usually surprised by the size of the gap.
The third is recall. Screening colonoscopy is a scheduled, recurring, guideline-driven demand stream. A practice with a working recall system has a predictable procedure pipeline; a practice without one is dependent on referral volume it does not control.
The Levers That Move Margin
These are the specific measurements we take. Each one is knowable from data you already have.
Endoscopy block utilization and turnover time
Measure block release rules, first-case on-time starts, and room turnover in minutes. Ten minutes of turnover across a full day is often an entire additional case, repeated every day the suite runs.
Anesthesia arrangement economics
Whether anesthesia is employed, contracted, or billed separately changes the per-case economics materially. Most groups inherited an arrangement and have never re-modeled it against current volumes.
Pathology and specimen workflow
Specimen handling, in-house versus send-out, and the terms of the current arrangement are all reviewable. This is one of the largest single ancillary decisions a GI group makes.
Screening recall and surveillance intervals
A functioning recall registry converts guideline-driven surveillance into predictable procedure volume. Most groups have the data in the EHR and no process that acts on it.
Infusion for IBD
Biologic infusion is a margin line with real operational requirements: authorization discipline, chair scheduling by therapy duration, and drug acquisition managed as a cost, not a pass-through.
Symptoms We Hear Most Often
If more than two of these describe your practice, there is measurable margin available.
- You cannot state last month's endoscopy block utilization without asking someone to build a report
- Suite days end late while earlier blocks went unfilled
- Surveillance patients fall out of the system between intervals
- Prior authorization for biologics is chased on the day of infusion
- Nobody has re-modeled the pathology or anesthesia arrangement in three years
How We Would Approach It
The same four-week baseline we run everywhere, pointed at the places that matter in this specialty.
Suite throughput baseline
We measure block utilization, first-case start time, turnover, and case-mix by provider, then rebuild the template around actual procedure durations rather than uniform slots.
Ancillary margin model
We model pathology, anesthesia, and infusion under the current arrangement and under realistic alternatives, so the decision is made against numbers instead of history.
Recall engine build
We stand up a surveillance registry with an owner, a cadence, and a report that shows how many due patients are unscheduled this month.
Denial and coding review for procedural claims
Procedural denial patterns are narrow and fixable. We group them by payer and reason, then close the top categories.
On Consolidation
GI has been among the most heavily consolidated specialties in the country. Independent groups that stay independent generally do it by running the procedure suite better than a platform can and by owning the ancillary economics themselves.
Start with your numbers.
Thirty minutes, your actual data, and an honest read on where the margin is in a gastroenterology practice.